MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia-Reference-Cited by-同舟云学术

MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia

Published:2006-07-18 Issue:7 Volume:3 Page:e270
ISSN:1549-1676
Container-title:PLoS Medicine
language:en
Short-container-title:PLoS Med

Author:

Pikman Yana,Lee Benjamin H,Mercher Thomas,McDowell Elizabeth,Ebert Benjamin L,Gozo Maricel,Cuker Adam,Wernig Gerlinde,Moore Sandra,Galinsky Ilene,DeAngelo Daniel J,Clark Jennifer J,Lee Stephanie J,Golub Todd R,Wadleigh Martha,Gilliland D. Gary,Levine Ross L

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference36 articles.

1. Editorial: Some Speculations on the Myeloproliferative Syndromes

2. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

3. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

4. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

5. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

Cited by 1214 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SOHO State of the Art Updates and Next Questions | Choosing and Properly Using a JAK Inhibitor in Myelofibrosis;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Structural basis of MPL activation by thrombopoietin;Blood Vessels, Thrombosis & Hemostasis;2024-09

3. Metformin use and risk of myeloproliferative neoplasms: a Danish population–based case-control study;Blood Advances;2024-08-27

4. Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms;Leukemia;2024-08-23

5. Endothelial LATS2 is a suppressor of bone marrow fibrosis;Nature Cardiovascular Research;2024-07-29